Related Experiment Videos
Pseudomembranous colitis associated with ampicillin and erythromycin therapy: report of a case
Abstract:
Pseudomembranous colitis has been observed increasingly often after therapy with several antibiotics. This report describes the case of a patient in whom pseudomembranous colitis developed in association with ampicillin, an extremely rare complication of this drug, and erythromycin, a drug that has not been previously reported to cause the disease. Clinical and pathologic features, pathogenesis, and management are discussed. Early diagnosis and treatment are extremely important to reduce the significant morbidity and mortality associated with this disorder.
Insights
Pseudomembranous colitis is a rare but serious condition increasingly linked to antibiotic use. This case highlights its occurrence with ampicillin and erythromycin, emphasizing the need for prompt diagnosis and treatment.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic-associated pseudomembranous colitis is a growing concern.
- Several antibiotics have been implicated in its development.
Observation:
- This report details a rare case of pseudomembranous colitis.
- The patient developed the condition following treatment with ampicillin and erythromycin.
- Erythromycin is a novel agent associated with this complication.
Findings:
- Pseudomembranous colitis is an extremely rare complication of ampicillin.
- Erythromycin has not been previously reported to cause pseudomembranous colitis.
- The clinical and pathological features, pathogenesis, and management are discussed.
Implications:
- Early diagnosis and prompt treatment are crucial for managing pseudomembranous colitis.
- Reducing significant morbidity and mortality associated with this disorder is paramount.
- This case expands the understanding of antibiotic-induced gastrointestinal complications.